(18)F-FDG Is a Surrogate Marker of Therapy Response and Tumor Recovery after Drug Withdrawal during Treatment with a Dual PI3K/mTOR Inhibitor in a Preclinical Model of Cisplatin-Resistant Ovarian Cancer.
about
Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors.Preclinical Evaluation of 18F-ML-10 to Determine Timing of Apoptotic Response to Chemotherapy in Solid Tumors(18)F-fluorodeoxyglucose uptake and tumor hypoxia: revisit (18)f-fluorodeoxyglucose in oncology application.Quantifying and correcting for tail vein extravasation in small animal PET scans in cancer research: is there an impact on therapy assessment?The Emerging Hallmarks of Cancer MetabolismCombined Injection of (18)F-Fluorodeoxyglucose and 3'-Deoxy-3'-[(18)F]fluorothymidine PET Achieves More Complete Identification of Viable Lung Cancer Cells in Mice and Patients than Individual Radiopharmaceutical: A Proof-of-Concept Study.FDG PET/CT imaging as a biomarker in lymphoma.Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician.NEMA NU 4-Optimized Reconstructions for Therapy Assessment in Cancer Research with the Inveon Small Animal PET/CT System.
P2860
Q27853324-2E933F4E-8227-4E86-9A2E-BC3E7AE79BB2Q33793270-26D3C72C-F717-4413-A3F8-3A8A94FF37D0Q33912335-BF87D853-A5A5-44B3-A0BD-A27D11735DEFQ36254165-7EF86C60-D44D-4F5B-8AEF-5EBCF6B39E7CQ36468964-F2AAB5D7-7D6F-4E19-BC46-5B7B466FF399Q37474422-FD271720-CFD2-4EFA-A9A0-39B7BC99CCEBQ38312367-B419CCB1-DF27-41CA-8014-A4E50160F171Q39233197-11D2CAEC-AD03-4670-8026-189CC95AA7C8Q41737043-FC41BA4A-49C1-46F2-99A7-C5C248E01B1A
P2860
(18)F-FDG Is a Surrogate Marker of Therapy Response and Tumor Recovery after Drug Withdrawal during Treatment with a Dual PI3K/mTOR Inhibitor in a Preclinical Model of Cisplatin-Resistant Ovarian Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
(18)F-FDG Is a Surrogate Marke ...... atin-Resistant Ovarian Cancer.
@en
type
label
(18)F-FDG Is a Surrogate Marke ...... atin-Resistant Ovarian Cancer.
@en
prefLabel
(18)F-FDG Is a Surrogate Marke ...... atin-Resistant Ovarian Cancer.
@en
P2093
P2860
P356
P1476
(18)F-FDG Is a Surrogate Marke ...... latin-Resistant Ovarian Cancer
@en
P2093
Abdelghani Jebahi
Alain Batalla
Charlotte Lecerf
Cécile Blanc Fournier
Florence Giffard
Laurent Poulain
Marie-Hélène Louis
Mélanie Briand
Stéphanie Lheureux
P2860
P304
P356
10.1593/TLO.13100
P577
2013-10-01T00:00:00Z